Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial

  • Timothy S. Maughan
  • , Richard A. Adams
  • , Christopher G. Smith
  • , Angela M. Meade
  • , Matthew T. Seymour
  • , Richard H. Wilson
  • , Shelley Idziaszczyk
  • , Rebecca Harris
  • , David Fisher
  • , Sarah L. Kenny
  • , Edward Kay
  • , Jenna K. Mitchell
  • , Ayman Madi
  • , Bharat Jasani
  • , Michelle D. James
  • , John Bridgewater
  • , M. John Kennedy
  • , Bart Claes
  • , Diether Lambrechts
  • , Richard Kaplan
    • Jeremy P. Cheadle

Research output: Contribution to journal › Article › peer-review

902 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 MRC COIN trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science